NovoCure
NVCR
NVCR
128 hedge funds and large institutions have $778M invested in NovoCure in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
23% more funds holding
Funds holding: 104 → 128 (+24)
4% more capital invested
Capital invested by funds: $746M → $778M (+$31.9M)
0.87% more ownership
Funds ownership: 42.2% → 43.07% (+0.87%)
Holders
128
Holding in Top 10
5
Calls
$20.2M
Puts
$4.46M
Top Buyers
| 1 | +$23.5M | |
| 2 | +$17.8M | |
| 3 | +$14.2M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$12.2M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$10.8M |
Top Sellers
| 1 | -$96.6M | |
| 2 | -$14.9M | |
| 3 | -$13M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$9.74M |
| 5 |
JG
Jefferies Group
New York
|
-$6.45M |